<p>Results for button press (A-D) and OKN (E and F) for patients with Parkinson’s disease (red) and controls (blue). In each panel, the non-rivalrous (non-riv) condition is on the left and the rivalrous (riv) condition is on the right. Error bars represent SEM across subjects. * and ** indicate significant difference between PD patients and controls at p<0.05 and p<0.01 respectively (unpaired two-tailed t-test).</p
<p>Comparison of oxidative stress and antioxidant peripheral biomarkers between patients with Parkin...
<p>DRS-2 = Dementia Rating Scale – 2<sup>nd</sup> Version total raw score (max = 144); WTAR = Wechsl...
The aim of this study was to test the concor- dance between disease severity, prevalence of nonmotor...
Comparison of the performance of the FAB-E scores between control group and Parkinson’s disease pati...
<p><i>Abbreviations</i>: <i>BMI (Boby Mass Index); UPDRS (Unified Parkinson's Disease Rating Scale);...
<p>Chi-squared test for p-values. RBD: Rapid eye movement behavior disorder, PD: Parkinson’s disease...
<p>Data are presented as mean, standard deviation, number and percentage.</p><p><b>HADS</b>: Hospita...
<p>The columns represent the mean percentage of correct response averaged across all the digit pairs...
We assessed degree of Parkinson disease motor symptom improvement with medication among subjects enr...
<p>The symbol * indicates a significant difference using <i>t</i>-test or U test (0.01 was used as t...
<p>Comparison of non-motor symptoms between subtypes of drug naïve Parkinson’s disease.</p
Objectives To validate the Fullerton Advanced Balance (FAB) Scale for patients with idiopathic Parki...
<p>For each patient sex, age, years since diagnosis, years since the implantation of the second DBS ...
<p>Number of reaching cycles, cycle asymmetry and coefficient of variation (CV) for the less and mor...
We assessed degree of Parkinson disease motor symptom improvement with medication among subjects enr...
<p>Comparison of oxidative stress and antioxidant peripheral biomarkers between patients with Parkin...
<p>DRS-2 = Dementia Rating Scale – 2<sup>nd</sup> Version total raw score (max = 144); WTAR = Wechsl...
The aim of this study was to test the concor- dance between disease severity, prevalence of nonmotor...
Comparison of the performance of the FAB-E scores between control group and Parkinson’s disease pati...
<p><i>Abbreviations</i>: <i>BMI (Boby Mass Index); UPDRS (Unified Parkinson's Disease Rating Scale);...
<p>Chi-squared test for p-values. RBD: Rapid eye movement behavior disorder, PD: Parkinson’s disease...
<p>Data are presented as mean, standard deviation, number and percentage.</p><p><b>HADS</b>: Hospita...
<p>The columns represent the mean percentage of correct response averaged across all the digit pairs...
We assessed degree of Parkinson disease motor symptom improvement with medication among subjects enr...
<p>The symbol * indicates a significant difference using <i>t</i>-test or U test (0.01 was used as t...
<p>Comparison of non-motor symptoms between subtypes of drug naïve Parkinson’s disease.</p
Objectives To validate the Fullerton Advanced Balance (FAB) Scale for patients with idiopathic Parki...
<p>For each patient sex, age, years since diagnosis, years since the implantation of the second DBS ...
<p>Number of reaching cycles, cycle asymmetry and coefficient of variation (CV) for the less and mor...
We assessed degree of Parkinson disease motor symptom improvement with medication among subjects enr...
<p>Comparison of oxidative stress and antioxidant peripheral biomarkers between patients with Parkin...
<p>DRS-2 = Dementia Rating Scale – 2<sup>nd</sup> Version total raw score (max = 144); WTAR = Wechsl...
The aim of this study was to test the concor- dance between disease severity, prevalence of nonmotor...